NMPA Approval

Composite Potassium Hydrogen Phosphate Injection

Approval Number

国药准字H20094204

Company山西普德药业有限公司

Registration Date

October 11, 2024

Drug Information

Generic Name

复合磷酸氢钾注射液

Dosage Form

注射剂

Strength

2ml:0.639g K2HPO4·3H2O与0.435g KH2PO4

Drug Type

化学药品

Registration Date

October 11, 2024

Company Information

Applicant Company

Company Name山西普德药业有限公司

Company Address

山西省大同经济技术开发区第一医药园区

Manufacturing Company

Company Name山西普德药业有限公司

Company Address

山西省大同经济技术开发区第一医药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复合磷酸氢钾注射液 - NMPA 批准文号 | MedPath